In vitro cytokine secretion in individuals with schizophrenia: results, confounding factors, and implications for further research.
The present paper reviews the results of all publications on in vitro cytokine secretion in patients with schizophrenia, as published by March 2001. The authors supply easy to read tables with respect to the individual cytokines and soluble cytokine receptors investigated, the in vitro methodology used, characterization of the patient samples, and the results on cytokine secretion as stated in these studies. Inconsistent results, e.g., regarding in vitro secretion of IL-2 with 11/18 studies finding decreased secretion, 5/18 finding no change, and 2/18 finding increases, cannot systematically be correlated with any methodological procedures nor any diagnostic subtypes, per se. However, factors such as medication and cigarette smoking are likely to play a role. The authors suggest that more hypothesis-driven research, together with more carefully designed studies, as well as better communication between basic or animal researchers and clinicians might help to answer the question of whether there are meaningful peripheral changes in the immune system related to schizophrenia.
Hinze-Selch
D
D
Department of Psychiatry and Psychotherapy, Christian-Albrechts University, Niemannsweg 147, D-24105 Kiel, Germany.
Pollmächer
T
T
D014150:Antipsychotic Agents / Q000627:therapeutic use; D016207:Cytokines / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D015213:Neuroimmunomodulation / Q000187:drug effects / Q000276:immunology; D012559:Schizophrenia / Q000188:drug therapy / Q000276:immunology*; D012907:Smoking
D014150:Antipsychotic Agents; D016207:Cytokines